1. Misregulation of DNA Methylation Regulators in Cancer
   Joyce J. Thompson et al, 2017 CrossRef
2. Prenatal Dexamethasone Exposure Induced Ovarian Developmental Toxicity and Transgenerational Effect in Rat Offspring
   Feng Lv et al, 2018 CrossRef
3. The tumor suppressor DLC1 inhibits cancer progression and oncogenic autophagy in hepatocellular carcinoma
   Hui-Ta Wu et al, 2018, Lab Invest CrossRef
4. A rare CHD5 haplotype and its interactions with environmental factors predicting hepatocellular carcinoma risk
   Qin Xiao et al, 2018, BMC Cancer CrossRef
5. The Chromodomain Helicase DNA-Binding Chromatin Remodelers: Family Traits that Protect from and Promote Cancer
   Alea A. Mills, 2017, Cold Spring Harb Perspect Med CrossRef
6. Emerging role of PI3K/AKT in tumor-related epigenetic regulation.
   Qi Yang et al, 2019, Semin Cancer Biol CrossRef
7. Etiology and Pathogenesis of Hepatocellular Carcinoma: Epigenetic Mechanisms
   Arthur Zimmermann, 2016 CrossRef
8. Placental DNA methylation levels at CYP2E1 and IRS2 are associated with child outcome in a prospective autism study
   Yihui Zhu et al, 2019 CrossRef
9. DNA Methylation Status in Cancer Disease: Modulations by Plant-Derived Natural Compounds and Dietary Interventions
   Karin Jasek et al, 2019, Biomolecules CrossRef
10. Etiology and Pathogenesis of Hepatocellular Carcinoma: Epigenetic Mechanisms
    Arthur Zimmermann, 2017 CrossRef
11. Cytotoxic and toxicogenomic effects of silibinin in bladder cancer cells with different TP53 status
    Daiane Teixeira de Oliveira et al, 2017, J Biosci CrossRef
12. Mutual regulation between CHD5 and EZH2 in hepatocellular carcinoma
    Cheng-Rong Xie et al, 2015, Oncotarget CrossRef
13. CpG methylation signature defines human temporal lobe epilepsy and predicts drug‐resistant
    Wenbiao Xiao et al, 2020, CNS Neurosci Ther CrossRef
14. Potential role of microRNA‑223‑3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics
    Rui Zhang et al, 2017, Mol Med Report CrossRef
15. Identification of the aberrantly methylated differentially expressed genes in proliferative diabetic retinopathy
    Aiwen Miao et al, 2020, Experimental Eye Research CrossRef
16. EZH2-Inhibited MicroRNA-454-3p Promotes M2 Macrophage Polarization in Glioma
    Bin Qi et al, 2020, Front. Cell Dev. Biol. CrossRef
17. A Study on the Effect of Vitamins A and C to Modulate the Expression of NKG2D Ligands in Hepatic and Colon Cancer Cells
    Mazin A. Zamzami et al, 2020, Nutrition and Cancer CrossRef
18. Tumor suppressor gene DLC1: Its modification, interactive molecules, and potential prospects for clinical cancer application
    Guanghui Ren et al, 2021, International Journal of Biological Macromolecules CrossRef
19. TXNIP, a novel key factor to cause Schwann cell dysfunction in diabetic peripheral neuropathy, under the regulation of PI3K/Akt pathway inhibition-induced DNMT1 and DNMT3a overexpression
    Xiang Zhang et al, 2021, Cell Death Dis CrossRef
20. ZNF191 alters DNA methylation and activates the PI3K‐AKT pathway in hepatoma cells via transcriptional regulation of DNMT1
    Yufeng Liu et al, 2022, Cancer Medicine CrossRef
21. The Cross-Talk between Epigenetic Gene Regulation and Signaling Pathways Regulates Cancer Pathogenesis
    Snigdha Samanta et al, 2022 CrossRef
22. Aberrant DNA Methylation Patterns of Deleted in Liver Cancer 1 Isoforms in Hepatocellular Carcinoma
    Junhai Pan et al, 2023, DNA and Cell Biology CrossRef
23. Oncogenic signaling-mediated regulation of chromatin during tumorigenesis
    Jahangir Alam et al, 2023, Cancer Metastasis Rev CrossRef
24. Decitabine-based nanoparticles for enhanced immunotherapy of hepatocellular carcinoma via DNA hypermethylation reversal
    Hongqiao Cai et al, 2024, Chemical Engineering Journal CrossRef